Mediterranean spotted fever: clinical and laboratory characteristics of 415 Sicilian children
2006

Mediterranean Spotted Fever in Sicilian Children

Sample size: 415 publication 10 minutes Evidence: moderate

Author Information

Author(s): Colomba Claudia, Saporito Laura, Polara Valentina Frasca, Rubino Raffaella, Titone Lucina

Primary Institution: Istituto di Patologia Infettiva e Virologia, Università di Palermo

Hypothesis

What are the clinical and laboratory characteristics of children with Mediterranean spotted fever and the efficacy of the drugs administered?

Conclusion

Clarithromycin can be considered a valid alternative therapy to tetracyclines or chloramphenicol for treating Mediterranean spotted fever in children under eight years old.

Supporting Evidence

  • Fever was present in 93% of cases.
  • 94.5% of children had a rash.
  • Chloramphenicol and macrolides were effective treatments.
  • Atypical exanthema was observed in 4.6% of cases.
  • The study included children aged 1 month to 15 years.

Takeaway

This study looked at sick kids in Sicily who had a disease from ticks. It found that a certain medicine works well for them.

Methodology

The study analyzed clinical and laboratory data from 415 children diagnosed with Mediterranean spotted fever at a children's hospital over eight years.

Potential Biases

Potential biases may arise from the observational nature of the study and reliance on clinical diagnosis.

Limitations

The study is limited to a specific geographic area and may not be generalizable to other regions.

Participant Demographics

Median age was 6 years, with 59% male participants.

Statistical Information

P-Value

p = 0.018

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2334-6-60

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication